A detailed history of Prostatis Group LLC transactions in Invesco ETF Tr S&P 500 Equal W stock. As of the latest transaction made, Prostatis Group LLC holds 40,824 shares of RCD stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares
40,824
Holding current value
$0
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.0 - $137.92 $0 - $5.63 Million
40,824 New
40,824 $40.8 Million
Q4 2022

Mar 23, 2023

BUY
$112.46 - $126.58 $3.92 Million - $4.41 Million
34,866 New
34,866 $34.9 Million
Q1 2020

Mar 23, 2023

SELL
$58.26 - $113.01 $218,416 - $423,674
-3,749 Closed
0 $0
Q4 2019

Mar 28, 2023

SELL
$100.34 - $111.93 $3.13 Million - $3.49 Million
-31,160 Reduced 89.37%
3,706 $412 Million
Q4 2019

Mar 23, 2023

BUY
$100.34 - $111.93 $376,174 - $419,625
3,749 New
3,749 $417 Million

Others Institutions Holding RCD

About INVESCO ETF TR S&P 500 EQUAL W


  • Ticker RCD
  • Sector ETFs
  • Industry ETFs
More about RCD
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.